Biological Mechanisms Involved in Muscle Dysfunction in COPD: An Integrative Damage–Regeneration–Remodeling Framework
Skeletal muscle dysfunction is a major systemic manifestation of COPD that shapes symptoms, exercise tolerance and mortality. Current evidence can be integrated within a Damage-Regeneration-Remodeling framework linking mechanics and biology to clinical phenotypes. Pulmonary hyperinflation and chest wall geometry chronically load the diaphragm and other respiratory muscles in COPD, whereas inactivity and exacerbation-related disuse underload locomotor muscles. Across muscle compartments, oxidative/nitrosative stress, activation of proteolytic pathways, mitochondrial and endoplasmic reticulum stress, microvascular limitations, neuromuscular junction instability, and myosteatosis degrade muscle quality. The diaphragm adapts with a fast-to-slow fiber shift, greater oxidative capacity, and sarcomere foreshortening, improving endurance, whereas limb muscles show atrophy, a glycolytic shift, reduced oxidative enzymes, extracellular matrix accrual, and fat infiltration. Translational levers that address these mechanisms include: (I) <i>Reduce damage</i>: bronchodilation, lung-volume reduction, oxygen, non-invasive ventilation, early mobilization, pulmonary rehabilitation, neuromuscular stimulation, and corticosteroid stewardship; (II) <i>Enable regeneration</i>: progressive resistance plus high-intensity/heavy-load endurance training; adequate protein and vitamin-D intake, and endocrine correction; and (III) <i>Steer remodeling</i>: increase physical activity (with/without coaching/telecoaching), functional assessment and CT or MRI monitoring, inspiratory-muscle training, and phenotype-guided adjuncts in selected cases. This framework clarifies why lung deflation strategies benefit inspiratory mechanics, whereas limb recovery requires behavioral and metabolic interventions layered onto systemic optimization.
Authors
- Carme Casadevall (ORCID: https://orcid.org/0000-0001-6458-8972)
- Sergi Pascual-Guàrdia (ORCID: https://orcid.org/0000-0002-6567-0916)
- Esther Barreiro (ORCID: https://orcid.org/0000-0003-2708-3443)
- Cesar Jessé Enríquez-Rodríguez (ORCID: https://orcid.org/0000-0002-5944-6555)
- Joaquim Gea (ORCID: https://orcid.org/0000-0001-8718-7346)
- Mauricio Orozco‐Levi (ORCID: https://orcid.org/0000-0002-3209-3462)
- Ramon Camps-Ubach (ORCID: https://orcid.org/0009-0009-7953-8455)
Institutions
- Universitat Pompeu Fabra (ES)
- Fundación Cardiovascular de Colombia (CO)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
Publication Details
- Journal
- Cells
- Published
- 2025-11-04
- DOI
- https://doi.org/10.3390/cells14211731
- Citations
- 2
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- European Commission
- Sociedad Española de Neumología y Cirugía Torácica
- Instituto de Salud Carlos III